MetaCap

Stereotaxis Inc. Company Profile

NYSE: STXSHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD

1.110.00 (0.00%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Stereotaxis at a glance

Stereotaxis Inc. (NYSE: STXS) is a Biotechnology: Electromedical & Electrotherapeutic Apparatus company in the Health Care sector headquartered in Saint Louis, MO. Stereotaxis is led by Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A. and employs about 131 people. At a market capitalization of $111.2 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0001289340, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Stereotaxis do?

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices. Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Business description based on the company's public filings.

Company information

Legal name
Stereotaxis Inc.
Ticker
NYSE: STXS
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
CEO
Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A.
Employees
131
Headquarters
710 North Tucker Boulevard, Saint Louis, MO, United States
Phone
314 678 6100
Market cap
$111.22M
SEC CIK
0001289340

Companies similar to Stereotaxis

STXS peer companies
CompanyPrice% ChgMarket capCompare
VANIVivani Medical Inc.1.25+1.63%$112.75Mvs STXS
HYPRHyperfine Inc. Class A0.9307-1.00%$98.70Mvs STXS
ECORelectroCore Inc.9.66+1.58%$87.09Mvs STXS
NRXSNeuraxis Inc.6.93+2.36%$87.03Mvs STXS
OMOutset Medical Inc.4.05-0.98%$76.13Mvs STXS
HSDTSolana Company Class A2.39+0.42%$155.60Mvs STXS
POCIPrecision Optics Corporation Inc.4.58-1.82%$50.26Mvs STXS
QTIQT Imaging Holdings Inc.2.68+3.08%$39.23Mvs STXS

Related